Kimia Biosciences gets nod to manufacture, market Azelnidipine API

29 Apr 2020 Evaluate

Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical ingredient Azelnidipine drug by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Share Price

47.26 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.